Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,665 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Noninvasive tumor hypoxia measurement using magnetic resonance imaging in murine U87 glioma xenografts and in patients with glioblastoma.
Linnik IV, Scott ML, Holliday KF, Woodhouse N, Waterton JC, O'Connor JP, Barjat H, Liess C, Ulloa J, Young H, Dive C, Hodgkinson CL, Ward T, Roberts D, Mills SJ, Thompson G, Buonaccorsi GA, Cheung S, Jackson A, Naish JH, Parker GJ. Linnik IV, et al. Among authors: young h. Magn Reson Med. 2014 May;71(5):1854-62. doi: 10.1002/mrm.24826. Epub 2013 Jun 24. Magn Reson Med. 2014. PMID: 23798369 Free article.
A two-part phase II study of cediranib in patients with advanced solid tumours: the effect of food on single-dose pharmacokinetics and an evaluation of safety, efficacy and imaging pharmacodynamics.
Mitchell CL, O'Connor JP, Roberts C, Watson Y, Jackson A, Cheung S, Evans J, Spicer J, Harris A, Kelly C, Rudman S, Middleton M, Fielding A, Tessier J, Young H, Parker GJ, Jayson GC. Mitchell CL, et al. Among authors: young h. Cancer Chemother Pharmacol. 2011 Sep;68(3):631-41. doi: 10.1007/s00280-010-1534-3. Epub 2010 Dec 1. Cancer Chemother Pharmacol. 2011. PMID: 21120480 Clinical Trial.
Advanced solid tumors treated with cediranib: comparison of dynamic contrast-enhanced MR imaging and CT as markers of vascular activity.
Messiou C, Orton M, Ang JE, Collins DJ, Morgan VA, Mears D, Castellano I, Papadatos-Pastos D, Brunetto A, Tunariu N, Mann H, Tessier J, Young H, Ghiorghiu D, Marley S, Kaye SB, deBono JS, Leach MO, deSouza NM. Messiou C, et al. Among authors: young h. Radiology. 2012 Nov;265(2):426-36. doi: 10.1148/radiol.12112565. Epub 2012 Aug 13. Radiology. 2012. PMID: 22891356 Clinical Trial.
Assessment of repeatability and treatment response in early phase clinical trials using DCE-MRI: comparison of parametric analysis using MR- and CT-derived arterial input functions.
Rata M, Collins DJ, Darcy J, Messiou C, Tunariu N, Desouza N, Young H, Leach MO, Orton MR. Rata M, et al. Among authors: young h. Eur Radiol. 2016 Jul;26(7):1991-8. doi: 10.1007/s00330-015-4012-9. Epub 2015 Sep 18. Eur Radiol. 2016. PMID: 26385804 Free PMC article. Clinical Trial.
Early reduction in tumour [18F]fluorothymidine (FLT) uptake in patients with non-small cell lung cancer (NSCLC) treated with radiotherapy alone.
Trigonis I, Koh PK, Taylor B, Tamal M, Ryder D, Earl M, Anton-Rodriguez J, Haslett K, Young H, Faivre-Finn C, Blackhall F, Jackson A, Asselin MC. Trigonis I, et al. Among authors: young h. Eur J Nucl Med Mol Imaging. 2014 Apr;41(4):682-93. doi: 10.1007/s00259-013-2632-3. Epub 2014 Feb 7. Eur J Nucl Med Mol Imaging. 2014. PMID: 24504503 Free PMC article.
2,665 results